Inactive Instrument
Canntab Therapeutics Limited Stock Canadian Securities Exchange
Stocks
PILL
CA1377991023
Pharmaceuticals
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Tech/Sci/R&D Officer | - | 2020-05-14 | |
Frank Candido
IRC | Investor Relations Contact | 61 | 2018-08-31 |
Eric Malinski
SAM | Sales & Marketing | - | 2018-04-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 38 | |
| -1.35% | -0.82% | -9.78% | -5.27% | 13.44B | |
| -2.94% | -3.76% | -30.91% | -51.86% | 5.08B | |
| -0.78% | +1.50% | -0.20% | +1.56% | 4.8B | |
| -3.19% | -0.61% | +2.12% | -33.68% | 4.05B | |
| -2.43% | -3.43% | +1.38% | -9.56% | 3.63B | |
| -1.33% | +1.56% | -2.06% | -4.58% | 3.63B | |
| -1.19% | +2.47% | -2.66% | +10.52% | 3.48B | |
| -2.28% | -0.77% | -14.46% | -24.09% | 2.4B | |
| -3.10% | -2.19% | -5.23% | +40.27% | 1.82B | |
| Average | -1.86% | -3.10% | -6.87% | -8.52% | 4.7B | |
| Weighted average by Cap. | -1.86% | -2.83% | -7.96% | -10.92% |
Employees
-
Sector
Pharmaceuticals
